$capr
Capricor Therapeutics' Deramiocel shows promising results in Phase [--] trials for Duchenne patients, gaining FDA Fast Track designation. However, the stock faces scrutiny from short sellers, leading to market volatility.
About $capr
Capricor Therapeutics is a biotechnology company focused on developing treatments for rare diseases, particularly Duchenne muscular dystrophy.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +16,530%
[--] Month: [-------] -62%
[--] Months: [---------] +228%
[--] Year: [----------] +177%
1-Year High: [---------] on 2025-12-03
1-Year Low: [---] on 2025-09-20
Engagements by network (24h): YouTube: [--] Reddit: [--] X: [-----]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Months: [---] +45,900%
1-Year High: [-----] on 2025-12-04
1-Year Low: [--] on 2025-04-12
Mentions by network (24h): YouTube: [--] Reddit: [--] X: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $capr in the last [--] hours which is down 30% from [--] in the previous [--] hours
Daily Average: [---]
[--] Months: [---] +25,100%
1-Year High: [-----] on 2025-12-04
1-Year Low: [--] on 2025-10-24
The most influential creators that mention $capr in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @l_e_whyte | [--] | [-------] | [--] | [---] |
| @Pro_Trader0000 | [--] | [--] | [--] | [---] |
| @Quantumup1 | [--] | [-----] | [--] | [---] |
| @oliviatrading_6 | [--] | [---] | [--] | [---] |
| @Jonk87 | [--] | [------] | [--] | [--] |
| @Dylanas19087 | [--] | [--] | [--] | [--] |
| @CHRISJO79766015 | [--] | [---] | [--] | [--] |
| @OptionsAlertsAi | [--] | [---] | [--] | [--] |
| @TradeLand_USA | [--] | [--] | [--] | [--] |
| @TradesProfits | [--] | [---] | [--] | [--] |
Sentiment: 62%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 62%
Daily Average: 80%
[--] Week: 50% -17%
[--] Month: 54% -11%
[--] Months: 54% -35%
[--] Year: 54% -17%
1-Year High: 100% on 2025-02-18
1-Year Low: 17% on 2025-09-24
Most Supportive Themes:
- Positive Clinical Trial Results: (60%) Capricor Therapeutics announced positive topline results from its Phase [--] HOPE-3 clinical study for Deramiocel, showing significant improvements in skeletal muscle and cardiac function for Duchenne patients.
- FDA Fast Track Designation: (20%) The FDA has granted a Fast Track designation for Deramiocel, indicating a potential for accelerated regulatory review and approval.
- Partnership with Nippon Shinyaku: (15%) The existing partnership with Nippon Shinyaku, which holds rights to Deramiocel in certain regions, is highlighted as a valuable asset.
Most Critical Themes:
- Short Seller Scrutiny and Short Squeeze: (70%) Prominent short sellers, including Martin Shkreli, have been vocal about their bearish stance on CAPR, with some facing significant losses due to a short squeeze.
- Market Volatility and Biotech Sector Risks: (20%) The biotech sector is inherently volatile, and concerns about overall market conditions and potential price corrections are present.
Top $capr Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Completed another [--] hour livestream on YouTube just now😼 Timestamps down below: 00:00 #Bitcoin and market crashing together soon $SPY $QQQ #Bitcoin 14:40 Could #Bitcoin have a V-shape recovery 16:30 #Altcoin season coming 21:55 $PLTR 24:40 $TSLA 25:45 $NVDA 26:15 $MSFT and #Bitcoin 28:00 $HIMS 30:50 $CAPR 31:25 $BABA and $HSI 35:50 $IREN 38:45 $KRYS 39:50 $DGXX 42:30 $FUTU 46:00 $SOFI $HOOD 47:40 $WULF $CLSK $MARA $BITF $GLXY $BTBT 50:30 $COIN 55:00 Final remarks https://twitter.com/i/web/status/2023824847164621249 https://twitter.com/i/web/status/2023824847164621249"
X Link @cantonmeow 2026-02-17T18:20Z 76.4K followers, [----] engagements
"@seedy19tron Hmmm. Did you shorted $OCUL or just enjoyed it from the sidelines 🍿 I prefer to short on the news instead of being screwed by a $CAPR "scenario". Just curious on your take on this"
X Link @MrN0b0dy 2026-02-17T16:23Z [---] followers, [---] engagements
"$QURE type a minutes this week Seems to be shrugging off last weeks bad news. No position. Interesting to see how the stock is reacting to $SPRB $IRON and $MRNA. Market is still sleeping on $CAPR imo with stellar p3 data the Vinay Prasad risk is mitigated"
X Link @bronxb_13 2026-02-17T15:57Z [--] followers, [---] engagements
"#earnings after the close on Monday November [--] [----] $RGTI $CRWV $BBAI $BYND (this time they mean it) $RKLB $ASTS $PLUG $WULF $OXY $MVST $HROW $ARCT $GEVO $GETY $HIT $CAPR $NRGV $BALY $DSP $EGY $CATX $MYO $INO $RRGB $GRDN $WPRT $REAL $HCAT $FLD $DCGO https://www.earningswhispers.com/calendar https://www.earningswhispers.com/calendar"
X Link @DurhamZach99678 2026-02-15T16:19Z [--] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing